Healthcare provider profile · identity verified

Camille Henry, MD

Internal Medicine · CAMDEN, NJ · NPI 1093865115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	747	191
Amlodipine Besylate	Amlodipine Besylate	417	99
Metformin Hcl	Metformin Hcl	309	74
Jardiance	Empagliflozin	276	47
Albuterol Sulfate Hfa	Albuterol Sulfate	263	78
Lisinopril	Lisinopril	236	63
Diclofenac Sodium	Diclofenac Sodium	224	70
Levothyroxine Sodium	Levothyroxine Sodium	221	55
Fluticasone Propionate	Fluticasone Propionate	213	64
Montelukast Sodium	Montelukast Sodium	213	58
Gabapentin	Gabapentin	198	43
Januvia	Sitagliptin Phosphate	189	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	165	39
Metoprolol Succinate	Metoprolol Succinate	143	33
Tamsulosin Hcl	Tamsulosin Hcl	139	26
Hydrochlorothiazide	Hydrochlorothiazide	137	37
Omeprazole	Omeprazole	137	41
Losartan Potassium	Losartan Potassium	128	28
Mirtazapine	Mirtazapine	127	27
Alendronate Sodium	Alendronate Sodium	126	32
Trulicity	Dulaglutide	116	22
Rosuvastatin Calcium	Rosuvastatin Calcium	108	26
Trazodone Hcl	Trazodone Hcl	104	26
Pravastatin Sodium	Pravastatin Sodium	101	24
Carvedilol	Carvedilol	99	27
Pregabalin	Pregabalin	87	19
Metformin Hcl Er	Metformin Hcl	81	26
Pantoprazole Sodium	Pantoprazole Sodium	77	22
Ammonium Lactate	Ammonium Lactate	76	21
Mounjaro	Tirzepatide	74	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	70	15
Baclofen	Baclofen	69	28
Famotidine	Famotidine	66	22
Ozempic	Semaglutide	61	13
Simvastatin	Simvastatin	54	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	53	21
Azelastine Hcl	Azelastine Hcl	52	16
Chlorthalidone	Chlorthalidone	52	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	52	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	16
Glimepiride	Glimepiride	49	suppressed
Furosemide	Furosemide	48	15
Naproxen	Naproxen	48	27
Ibuprofen	Ibuprofen	47	17
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Donepezil Hcl	Donepezil Hcl	42	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Cromolyn Sodium	Cromolyn Sodium	40	17
Eliquis	Apixaban	38	suppressed
Incruse Ellipta	Umeclidinium Bromide	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Lidocaine	Lidocaine	36	13
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Prednisone	Prednisone	33	31
Valsartan	Valsartan	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	19
Ulticare Pen Needle	Pen Needle, Diabetic	31	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	29	suppressed
Allopurinol	Allopurinol	29	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	29	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Glipizide	Glipizide	28	11
Humalog Kwikpen U-100	Insulin Lispro	28	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Repaglinide	Repaglinide	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Meloxicam	Meloxicam	26	14
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	12
Comfort Ez Pen Needle	Pen Needle, Diabetic	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Atenolol	Atenolol	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Finasteride	Finasteride	21	suppressed
Humalog Kwikpen U-200	Insulin Lispro	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	19	suppressed
Nateglinide	Nateglinide	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Unifine Pentips	Pen Needle, Diabetic	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error